D-0127-2018 Class III Terminated
FDA drug recall D-0127-2018 was initiated by Claris Lifesciences Inc on Nov 6, 2017 and is designated Class III. Reason for recall: Superpotent The recall status is terminated (terminated Apr 20, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Nov 6, 2017
- Termination Date
- Apr 20, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249
Reason for recall
Superpotent
Distribution pattern
Nationwide
Code information
A060192 01/2018; A060305 02/2018; A061038 08/2018; A0A0068 12/2018; A0A0404 04/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0127-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026